Roche strong at nine months
This article was originally published in Scrip
Roche has reported strong 3Q sales figures that beat expectations by 2%. Group sales for the nine months ended 30 September were up 5% in constant currencies and flat in Swiss Francs at CHF34.76bn compared with the first nine months of 2013. Sales from its pharmaceuticals division stood at CHF26.97bn, up 4% at CER but down 1% in local currency.